CLE CCC Golden Medium Deep 2.1 mg/30mL
Titanium Dioxide, Octinoxate, Octisalate · CREAM · KW ABSC, INC.
CLE CCC Golden Medium Deep is a cream containing titanium dioxide, octinoxate, octisalate at 2.1 mg/30mL, taken topical. Manufactured by KW ABSC, INC..
Key Facts
- Brand Name
- CLE CCC Golden Medium Deep
- Generic Name
- Titanium Dioxide, Octinoxate, Octisalate
- NDC Code (Product)
69231-027- Manufacturer
- KW ABSC, INC.
- Strength
- 2.1 mg/30mL
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- part352
- Marketing Start
- 12/03/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is CLE CCC Golden Medium Deep used for?
CLE CCC Golden Medium Deep contains Titanium Dioxide, Octinoxate, Octisalate. It is a cream taken topical. Consult your doctor for specific uses.
Is CLE CCC Golden Medium Deep a controlled substance?
CLE CCC Golden Medium Deep is not classified as a controlled substance by the DEA.
What is the generic name for CLE CCC Golden Medium Deep?
The generic name for CLE CCC Golden Medium Deep is Titanium Dioxide, Octinoxate, Octisalate. There are 11 other brand versions of Titanium Dioxide, Octinoxate, Octisalate.
What is the NDC code for CLE CCC Golden Medium Deep 2.1 mg/30mL?
The NDC (National Drug Code) for CLE CCC Golden Medium Deep 2.1 mg/30mL is 69231-027, listed by KW ABSC, INC..
Other Titanium Brands
See all →- JUNGSAEMMOOL Essential Skin Nuder Cushion Fair67 mg/g71261-027
- CLE CCC Neutral Light2.1 mg/30mL69231-028
- JUNGSAEMMOOL Essential Skin Nuder Cushion Light67 mg/g71261-030
- CLE CCC Warm Medium Deep2.1 mg/30mL69231-026
- JUNGSAEMMOOL Essential Skin Nuder Cushion Pink Light67 mg/g71261-031
- JUNGSAEMMOOL Essential Skin Nuder Cushion N-Light67 mg/g71261-032
- JUNGSAEMMOOL Essential Skin Nuder Cushion Medium Deep67 mg/g71261-034
- CLE CCC Golden Medium2.1 mg/30mL69231-034
- CLE CCC Neutral Deep.156 mg/30mL69231-036
- JUNGSAEMMOOL Essential Skin Nuder Cushion Bronze67 mg/g71261-039
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)